Webinar: High-Throughput Developability Assessment of Therapeutic Antibody Candidates in Discovery Stage

Relive our June 20th webinar! Instant Replay


Stay tuned for our next conference!

New Resources

Download our new capabilities brochure!

What our customers are saying…

…a solid performer for my company’s animal studies…
Elisabeth Gardiner, PhD Chief Scientific Officer Meditope Biosciences, Inc.

Press Releases


GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.


Aragen Bioscience Expands Cell Line Development Services

Aragen Bioscience Announces AAALAC Accreditation